26 years old | 0
    male | 0
    previously diagnosed with restrictive subaortic ventricular septal defect | -6480
    previously diagnosed with mild pulmonary hypertension | -6480
    no history of drug abuse | 0
    presented to the hospital in critical condition | 0
    hypochromic anemia | -6480
    fatigue | -6480
    effort limitation | -6480
    exertional dyspnea | -6480
    ascites | -6480
    persistent inflammatory syndrome | -6480
    weight loss of 20 kg | -6480
    increased blood cell count | 0
    C-reactive protein 76 mg/L | 0
    procalcitonin 0.77 ng/mL | 0
    anemia | 0
    thrombocytopenia | 0
    echocardiography revealing infective endocarditis | 0
    mobile vegetations | 0
    severe regurgitation of aortic valve | 0
    severe regurgitation of tricuspid valve | 0
    severe regurgitation of pulmonary valve | 0
    aortic annulus abscess | 0
    restrictive ventricular septal defect | 0
    severely dilated left ventricle | 0
    dilated right ventricle | 0
    severe biventricular dysfunction | 0
    left ventricle ejection fraction 25% | 0
    tricuspid annular plane systolic excursion 11 mm | 0
    severe pulmonary hypertension | 0
    broad-spectrum antibiotics initiated | 0
    antifungals initiated | 0
    septic shock | 0
    multiple organ dysfunction syndrome | 0
    hypotension | 0
    hypoxemia | 0
    severe metabolic acidosis | 0
    oliguria | 0
    thrombocytopenia | 0
    neurologic dysfunction | 0
    mechanical ventilation | 0
    hemodynamic support with dobutamine | 0
    hemodynamic support with norepinephrine | 0
    continuous venovenous hemodiafiltration | 0
    cytokine removal filter | 0
    gram-negative bacilli found on blood cultures | 0
    meropenem prescribed | 0
    gradual clinical improvement | 168
    weaning of norepinephrine | 168
    weaning of mechanical ventilation | 168
    organ functions recovered | 168
    ventricular function improved | 168
    LV ejection fraction 30% | 168
    TAPSE 16 | 168
    elevated pulmonary artery pressure | 168
    dobutamine-dependent | 168
    paroxysmal supraventricular tachycardia | 384
    septic discharge | 384
    fever >39Â°C | 384
    WBC increase | 384
    recurrence of septic shock | 384
    hemodynamic deterioration | 384
    lactate increase | 384
    transient hepatic cytolysis | 384
    oliguria | 384
    clinical improvement after electrical conversion | 384
    administration of dobutamine | 384
    administration of levosimendan | 384
    surgery performed | 432
    bicaval-aortic cardiopulmonary bypass | 432
    Custodiol cardioplegia | 432
    aortic valve replaced | 432
    tricuspid valve replaced | 432
    pulmonary valve replaced | 432
    aortic annular abscess debrided | 432
    VSD closed with bovine pericardial patch | 432
    sinus rhythm recovered | 432
    dobutamine used post-CPB | 432
    norepinephrine used post-CPB | 432
    inhaled nitric oxide | 432
    ultrafiltration with cytokine removal | 432
    postoperative outcome good | 432
    stable hemodynamics | 432
    no arrhythmias | 432
    extubation | 456
    Milrinone infusion | 456
    levosimendan administration | 576
    inotrope withdrawal | 576
    LVEF below 35% | 576
    sacubitril/valsartan started | 576
    valve cultures positive for Rhizobium radiobacter | 432
    intravenous meropenem continued | 576
    levofloxacin started | 576
    co-trimoxazole started | 576
    resumed work | 4320
    normally functioning valves | 4320
    improved ventricular function | 4320
    no sign of infection | 4320
    asymptomatic at 18 months | 12960
    LVEF 50% | 12960
